Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation – Prospective Trial of Once-Daily vs. Twice-Daily Tac – 5 Years Second Report.
T. Tsuchiya, H. Ishida, T. Nozaki, H. Shirakawa, T. Shimizu, K. Omoto, M. Okumi, K. Tanabe.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background; Previously, we reported a comparison of the safety and pharmacokinetics between a prolonged-release formulation of Tacrolimus (Tac-QD) and twice-daily tacrolimus (Tac-BD) in the early…
2016 American Transplant Congress
Impediments to Timely Listing for HIV+ Patients Being Evaluated for Kidney Transplantation.
D. Lee,¹ A. Aldea,¹ M. Harhay,² S. Akshay,² G. Malat,³ N. Law,¹ S. DeBellis,² T. Bias,¹ S. Boyle,² K. Ranganna,² A. Doyle.²
¹Division of Infectious Diseases and HIV Medicine, Drexel University, Philadelphia; ²Division of Nephrology, Drexel University, Philadelphia; ³Department of Surgery, Drexel University, Philadelphia.
Introduction:HIV+ individuals can be transplanted safely and effectively but face additional barriers in evaluation and listing.MethodsWe performed a single center chart review of all HIV+…
2016 American Transplant Congress
A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.
B. Kaplan, K. MaCague, D. Patel, F. Vincenti.
Mayo Clinic, Phoenix; Novartis Pharmaceuticals Corporation, East Hanover; University of California, San Francisco.
The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior to CellCept® (mycophenolate mofetil…
2016 American Transplant Congress
Validation of the Kidney Donor Risk Index (KDRI) in the Australian and New Zealand Kidney Transplant Population.
P. Clayton,^1,2,3 S. White,^1,4 S. McDonald,^1,2,3 S. Chadban.^1,4,5
¹Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Royal Adelaide Hospital, Adelaide, SA, Australia; ²Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; ³School of Medicine, University of Adelaide, Adelaide, SA, Australia; ⁴Sydney Medical School, University of Sydney, Sydney, NSW, Australia; ⁵Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Purpose: The kidney donor risk index (KDRI), developed by the United States Scientific Registry of Transplant Recipients (SRTR), was designed to quantify donor kidney quality.…
2016 American Transplant Congress
Soluble ST2 and Cardiovascular (CV) Outcomes and Mortality in Kidney Transplant Candidates.
M. Keddis,¹ Z. El-Zoghby,² A. Gray,² J. Meeusen,² L. Donato,² F. Cosio,² D. Steidley.¹
¹Mayo Clinic, Phoenix, AZ; ²Mayo Clinic, Rochester, MN.
Introduction: Soluble ST2(sST2), involved in T-cell mediated inflammation and cardiac fibrosis, is a better predictor of cardiovascular events(CVE) in heart failure(HF) and is less affected…
2016 American Transplant Congress
The Effect of Tocilizmab Treatment (TCZ-Rx) on IgG Subclasses in HLA-sensitized (HS) Kidney Transplant Patients Treated with TCZ.
B.-H. Shin, S. Ge, J. Choi, J. Kahwaji, A. Vo, A. Petrosyan, S. Jordan, M. Toyoda.
Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Background: Antibody-mediated rejection (ABMR) is a major obstacle for successful transplant in HS patients. TCZ has anti-B cell and anti-inflammatory properties. We have reported its…
2016 American Transplant Congress
Evaluation of Dose Dependent Rabbit Anti-Thymocyte Globulin Induction in Risk-Stratified Kidney Transplant Recipients.
I. Gutman, M. Misel, D. McKay, A. Hemming, J. Kerr, K. Mekeel.
UC San Diego Health System, San Diego, CA.
Background: Rabbit anti-thymocyte globulin (rATG) is a depleting polyclonal antibody often used for induction following kidney transplantation to help prevent acute rejection. The optimal dosage…
2016 American Transplant Congress
The Environmental Impact of Dialysis vs Transplantation.
M. Grafals,¹ R. Sanchez.²
¹Medstar Georgetown Transplant Institute, Georgetown University, Washington, DC; ²Environmental Health, Harvard University, Boston, MA.
Introduction: Hemodialysis has a large environmental impact because it uses large volumes of water, medical supplies and energy. A patient undergoing weekly dialysis treatment (three…
2016 American Transplant Congress
Robotic-Assisted Laparoscopic Donor Nephrectomy with Transvaginal Extraction of the Kidney.
C. Champy,¹ L. Salomon,¹ I. Cholley,¹ A. Hoznek,¹ R. Yiou,¹ D. Vordos,¹ P. Grimbert,² P. Lang,² A. De La Taille.¹
¹Urology Department - INSERM U955, Henri Mondor, Créteil, France; ²Nephrology Department, Henri Mondor, Créteil, France.
Minimally invasive surgery aims to the reduction of complications, pain and scars. Thus, vaginal extraction of the donor's kidney has been reported as an option…
2016 American Transplant Congress
Predicting Delayed Kidney Graft Function with Gene Expression in Preimplantation Biopsies.
T. Mourão,^1,3 K. Mine,¹ E. Campos,^1,3 J. Medina-Pestana,^2,3 H. Tedesco-Silva,² M. Gerbase-De Lima.
¹Immunogenetics Institute, Associação Fundo de Incentivo à Pesquisa - AFIP, São Paulo, SP, Brazil; ²Hospital do Rim e Hipertensão, Fundação Oswaldo Ramos, São Paulo, SP, Brazil; ³UNIFESP, São Paulo, SP, Brazil.
Aiming to further the investigation of markers in pre-implantation biopsies (PIB) for the prediction of delayed graft function (DGF), we analyzed, in a different cohort…